Cellectar Biosciences, Inc.
CLRB · XNASCIK 1279704fmd_14DA51B3FT8B22VFCM8TP8850RManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2003 to Sep 30, 2026, 73 periods
AI-written
A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.
Loading